Amanote Research
Register
Sign In
Second-Line-Therapie Mit Axitinib Als Referenzstandard?
Best Practice Onkologie
- Germany
doi 10.1007/bf03359835
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
August 1, 2011
Authors
Unknown
Publisher
Springer Science and Business Media LLC